All companies
Visit website
Scripx Pharmacy & Health
OperatingScripx, Inc.
Healthcare · Technology · Founded 2021
Evolving the access and affordability of medications via tech and automation
Valuation cap ⓘ
$12.0M
As of Feb 2023 · from Scripx Pharmacy & Health Crowd SAFE 1 · a SAFE/note conversion ceiling, not a priced valuation
Total raised
$45,951
Across 1 round since 2022
Latest share price
$1.00
Scripx Pharmacy & Health Crowd SAFE 1 offering price
Financials
FY2020–FY2021 · from SEC filings · hover any figure for its source$558K
−$127K
2020
$1.9M
−$372K
2021
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2020
FY2021
Income statement
Revenue
$557,891
$1,910,831
Cost of goods sold
$453,488
$1,928,213
Gross margin
19%
-1%
Net income
-$126,692
-$372,099
Taxes paid
$0
$0
Balance sheet
Cash
$6,579
$63,513
Accounts receivable
$85,476
$119,000
Total assets
$218,821
$940,877
Short-term debt
$131,483
$333,389
Long-term debt
$7,872
$761,455
Total liabilities
$139,355
$1,094,844
Other
Headcount
—
8
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Post-money = pre-money + amount raised · caps marked$12.0M
Valuation cap
Scripx Pharmacy & Health Crowd SAFE 1
A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
Fundraising history
Raised $46K / $1.1MInvestors 105Valuation cap $12M
Reg CF annual-report compliance
Delinquent
Filed 0 of 4 annual reports (FY2022–FY2025)
Missing: 2022, 2023, 2024, 2025
105 investors
holder-count proxy
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
Source: ManualCIK 0001943843Share price $1.00
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.